CMS Maximum Fair Price
Description
Because of the prescription drug law, known as the Inflation Reduction Act, Medicare is able to negotiate directly with drug companies to improve access to some of the costliest single-source brand-name Medicare Part B and Part D drugs.
More Information about Initial Price Applicability Year 2026 Policy, Selected Drugs, and Public Input Opportunities
More Information about Initial Price Applicability Year 2027 Policy
Source: Medicare Drug Price Negotiation | CMS
🤚 Request this data source
Source links
Download
Negotiated Prices for Selected Drugs in the First Negotiation Cycle
Medicare Drug Price Negotiation | CMS
Medicare Drug Price Negotiation
www.cms.gov
API
Licensing
Update frequency
The file is updated annually each year subsequent to the first initial price applicability year of the price applicability period for each selected drug, at a minimum, to show the inflation-adjusted negotiated price for the selected drug. Additional updates are made on a recurring basis to account for the application of the negotiated price to new NDC-11s of selected drugs or when an NDC-11 should no longer have the negotiated price applied. Lastly, additional updates are made to account for when a drug is no longer selected. CMS will publish the file in both .xlsx and .csv file formats.
Table info
Selected Drug List (ZIP)
This list contains 10 drugs covered under Medicare Part D that were selected for the first cycle of negotiation based on Total Expenditures under Part D and other criteria as required by the law; the list will be updated over time. Potential updates to the list include the addition of drugs covered under Medicare Part D or Part B selected for negotiation in future years.
File for Negotiated Prices, also known as Maximum Fair Prices in Statute (ZIP)
This file contains information on the negotiated prices under the Medicare Drug Price Negotiation Program, which the statute refers to as Maximum Fair Prices (MFPs), for 10 drugs covered under Medicare Part D that will go into effect beginning January 1, 2026, based on negotiations and agreements reached between CMS and participating drug companies. The file contains the single negotiated price for a 30-day equivalent supply of each selected drug, NDC-9 per unit price, and NDC-11 per package price. The file also contains other important information regarding updates to the NDCs and MFPs.
The file is updated annually each year subsequent to the first initial price applicability year of the price applicability period for each selected drug, at a minimum, to show the inflation-adjusted negotiated price for the selected drug. Additional updates are made on a recurring basis to account for the application of the negotiated price to new NDC-11s of selected drugs or when an NDC-11 should no longer have the negotiated price applied. Lastly, additional updates are made to account for when a drug is no longer selected. CMS will publish the file in both .xlsx and .csv file formats.
Fact Sheet: Negotiated Prices for Initial Price Applicability Year 2026 (PDF)
On this page
- CMS Maximum Fair Price
- Description
- Source links
- Download
- API
- Licensing
- Update frequency
- Table info